COVID vaccine "will protect for about a year," requiring (mandatory) MULTIPLE injections
Mark Crispin Miller
COVID Vaccine Will Only be Good for a Short Time – Multiple Shots Will be Needed
Comments by Brian Shilhavy
Editor, Health Impact News
Pharmaceutical companies racing to fast-track a COVID vaccine are already warning the public that any vaccine that comes into the market will probably only offer temporary “protection,” laying the ground work for a COVID vaccine that will probably be similar to the annual flu vaccine, where a new shot is needed every year.
The flu vaccine is already the most dangerous vaccine in the market, comprising the bulk of settlements for injuries and deaths in the U.S. Vaccine Court. (Previously published reports for vaccine settlements for injuries and deaths by the DOJ are found here.)
FiercePharma, the marketing trade publication for the vaccine industry, quoted AstraZeneca CEO Pascal Soriot from an interview he gave on a Belgian radio station:
“We think that it will protect for about a year.”
FiercePharma also reports that AstraZeneca expects to have their vaccine ready by October this year:
Soriot said that “if all goes well, we will have the results of the clinical trials in August/September,” as quoted by Reuters.
“We are manufacturing in parallel,” he added. “We will be ready to deliver from October if all goes well.”
Soriot is not the only one saying that multiple shots will be needed for COVID treatment. Dr. Fauci has said the same thing, as Marco Cáceres reports in this article from The Vaccine Reaction.
COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually
by Marco Cáceres
The Vaccine Reaction
In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary.
“If you look at the duration of protection when you recover from one of the several benign coronaviruses that cause the common cold, the durability of infection is only measured in a year or less as opposed to the other infections where you can get 15 to 20 years of protection,” Dr. Fauci said.1 2 3
Fauci and others developing or promoting COVID-19 vaccination are talking about the likelihood that the new coronavirus vaccine will have to be administered in multiple doses, perhaps even annually like the influenza vaccine.
There are more than 100 research programs around the world working on candidate vaccines for COVID-19, including 10 that have reached the clinical evaluation stage, either phase 1 or phase 2.
Among these are programs led by Western pharmaceutical companies such as AstraZeneca plc (in partnership with the University of Oxford); BioNTech SE partnered with Pfizer, Inc.; Inovio Pharmaceuticals, Inc.; Moderna, Inc. (in partnership with NIAID) and Novavax, Inc.
Another 123 programs to develop a COVID-19 vaccine remain in preclinical evaluation.4
Click on the link for the rest.